GTBP
GT Biopharma Inc. Common Stock
$2.820+0.000 (0.000%)
Echtzeitkurs
Kursdiagramm
Loading Chart...
Schlüsselkennzahlen
Marktkennzahlen
Eröffnung
$2.820
Hoch
$2.820
Tief
$2.820
Volumen
0.07M
Unternehmensfundamentaldaten
Handelsstatistiken
Ähnliche Nachrichten
GlobeNewswire
GT Biopharma Advances GTB-3650 Phase 1 Trial to Cohort 2 Following Successful Initial Human Dosing and Evidence of Early Immune Activation Signals
Following the formal safety review of Cohort 1, no safety or tolerability issues were observed, allowing the company to move forward with Cohort 2. The company plans on releasing more detailed results from Phase 1 later
Mehr anzeigen
Ähnliche Aktien
WIA
Western Asset Inflation-Linked Income Fund
NASDAQ
Trusts außer Bi...
IPAR
Inter Parfums Inc.
NASDAQ
Package Goods/C...
NHC
National HealthCare Corporation
NASDAQ
Hospital/Nursin...
COGT
Cogent Biosciences Inc.
NASDAQ
Biotechnologie:...
OXLCN
Oxford Lane Capital Corp. 7.125% Series 2029 Term Preferred Stock
NASDAQ
Investmentmanag...
Bleiben Sie auf dem Laufenden
Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.